Drug developer BenevolentAI faces founder-led board revolt

BenevolentAI, a British-based drug developer, is facing a boardroom coup led by its founder after seeing its shares slump since it floated little more than two years ago.

Related Keywords

United Kingdom ,Amsterdam ,Noord Holland ,Netherlands ,Inchcape ,Fife ,Neil Woodford ,Joerg Moeller ,Ken Mulvany ,Yoel Zaoui ,David Cameron ,Francois Nader ,Astrazeneca ,Euronext ,Baroness Shields ,Sky News ,Inchcape United ,